Adult Neurology Residency

Adult Neurology Residency

Global Health

Introduction and Goals

This is a 3 week rotation with the neurology residents and faculty of Addis Ababa University (AAU), under supervision by at least one accompanying faculty of UW Neurology.

By way of background, the  AAU Neurology residency was begun in 2007 with the assistance of academic neurologists from several European Universities, as well as Dr. James Bower of Mayo Clinic Neurology. It has blossomed into a comprehensive training platform, and the most well developed residency of its kind in sub-Saharan Africa. We were honored by an invitation to participate in training in 2013, following participation of several UW residency directors in other specialties, notably emergency medicine, surgery, Ob-Gyn, medicine, and pediatrics.

Senior UW Neurology residents engage in both outpatient and inpatient activities, primarily in the role of observers, at the two AAU hospitals: Black Lion (Takur Anbessa) and Crown (Zewditu). Our residents learn to adapt both their clinical skills and diagnostic acumen to an environment of significant resource limitation. Ethiopia is a very poor country, and the awareness garnered from exposure to the highly skilled care of our Ethiopian colleagues in this environment is immensely valuable.

Perhaps the most valuable component of all is the learning of “cultural humility”, wherein our residents – and faculty alike – learn the distinction between our clinical intuition and the rapid gratification of our technology in both diagnosis and treatment of very severe neurological disorders.

We feel honored to have this opportunity, and the experience in terms of technical lessons of neurological disorders as well as cultural enrichment is as valuable as it is unforgettable. 

Objectives and Evaluation Matrix

As with all of the neurology rotations, the specific objectives are reflected in the entrustable professional activities and individual milestones listed below. These form the basis for the end-of-rotation evaluation. (Please see the section End-of-Rotation Evaluations above for the list of milestone abbreviations).

Rotation Objectives
Upon completion of the curriculum, residents will . . .
1Evaluate and manage tropical infectious diseasesPC1, PC2, PC3, PC4, PC5, PC8, MK1, MK2
2Describe the impact of extreme poverty and nutritional deprivation on disease susceptability and presentationSP3, SP4
3Direct the diagnostic evaluation of disease in a resource-limited environmentMK2, SP3, SP4
4Collaborate with international colleagues in patient care and on lectures and grand roundsPR1, IC3, IC4
5Demonstrate competence in adapting to a different cultureSP3, SP4, PL2, PR1, IC2
Additional Milestones
Please grade the resident on any of the following milestones you were able to evaluate during this rotation:
PR2, IC1
Comments are visible both to residents and the Clinical Competency Committee


The morning begins with morning report followed by a 1 hour lecture on a topic selected by either a UW or AAU neurology resident. Rounds at one of the hospitals then goes until noon; the residents are split up so that they attend these or an outpatient clinic. These roles are then reversed the following day. In both situations, our residents gain immensely from exposure to a variety of neurological conditions and tropical infectious diseases they would seldom see here; while the AAU residents gain from learning approaches of the higher technology we apply to our own approaches.

Work Hours

The estimated average number of work hours per week is ~ 30. There are no call responsibilities required during this rotation.


Suggested References

  1. The 17 neglected tropical diseases.
  1. Deribe K, Meribo K, Gebre T, Hailu A, Ali A, Aseffa A, Davey G. The burden of neglected tropical diseases in Ethiopia, and opportunities for integrated control and elimination. Parasit Vectors. 2012 Oct 24;5:240.
  1. Winkler AS. Neurocysticercosis in sub-Saharan Africa: a review of prevalence, clinical characteristics, diagnosis, and management. Pathog Glob Health. 2012 Sep;106(5):261-74.
  1. Vale TC, de Sousa-Pereira SR, Ribas JG, Lambertucci JR. Neuroschistosomiasis mansoni: literature review and guidelines. Neurologist. 2012 Nov;18(6):333-42.
  1. Sindic CJ. Infectious neuropathies. Curr Opin Neurol. 2013 Oct;26(5):510-5
  1. Rodrigues LC, Lockwood DNj. Leprosy now: epidemiology, progress, challenges, and research gaps. Lancet Infect Dis. 2011 Jun;11(6):464-70.
  1. Kennedy PG. Clinical features, diagnosis, and treatment of human African trypanosomiasis (sleeping sickness). Lancet Neurol. 2013 Feb;12(2):186-94.
  1. Smith JL, Flueckiger RM, Hooper PJ, Polack S, Cromwell EA, Palmer SL, Emerson PM, Mabey DC, Solomon AW, Haddad D, Brooker SJ. The geographical distribution and burden of trachoma in Africa. PLoS Negl Trop Dis. 2013 Aug 8;7(8): Bhosai SJ, Bailey RL, Gaynor BD, Lietman TM. Curr Opin Ophthalmol. 2012 Jul;23(4):288-95
  1. Yalew KN, Mekonnen MG, Jemaneh AA. Trachoma and its determinants in Mojo and Lume districts of Ethiopia. Pan Afr Med J. 2012;13 Suppl 1:8.
  1. Gage JT, Vance EA, Hildenbrand PG, and Mattison T.  Brain lesion and AIDS. Proc Bayl Univ Med Cent  2000 Oct; 13(4): 424–429.
  1. Amogne W, Teshager G, Zenebe G. Central nervous system toxoplasmosis in adult Ethiopians. Ethiop Med J. 2006 Apr;44(2):113-20.
  1. Vinnard C, Macgregor RR. Tuberculous meningitis in HIV-infected individuals. Curr HIV/AIDS Rep. 2009 Aug;6(3):139-45.
  2. Jerene D, Naess A, Lindtjorn B. Antiretroviral therapy at a district hospital in Ehtiopia prevents death and tuberculosis in a cohort of HIV patients. AIDS Research and Therapy 2006;3;10 – 18.
  1. Dzoyem JP, Kechia FA, Ngaba GP, Lunga PK, Lohoue PJ. Prevalence of cryptococcosis among HIV-infected patients in Yaounde, Cameroon. Afr Health Sci. 2012 Jun; 12(2): 129–133.
  1. Alemu AA, Kempker RR, Tenna A, Smitson  C, Berhe N, Fekade D, Aseffa A. High Prevalence of Cryptococcal Antigenemia among HIV-infected Patients Receiving Antiretroviral Therapy in Ethiopia. PLoS One. 2013; 8(3): e58377.
  1. Longley N, Muzoora C, Taseera K, Mwesigye J, Rwebembera J, Chakera A, Wall E, Andia I, Jaffar S, Harrison TS. Dose response effect of high-dose fluconazole for HIV-associated cryptococcal meningitis in southwestern Uganda. Clin Infect Dis. 2008 Dec 15;47(12):1556-61.
  1. Mossie TB, Kassa AW, Tegegne MT. HIV dementia among HIV positive people at Debre markos hospital in Northwestern Ethiopia. Amer J Psychiatry Neurosci 2014: 2(2); 18-24.
  1. Lawn SD, Harries AD, Anglaret X, Myer L, Wood R. Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa. AIDS. 2008 Oct 1; 22(15): 10 – 27.
  1. Yakasai AM, Gudaji MI, Muhammad H, Ibrahim A, Owolabi LF, Babashni M, Mijinyawa MS, Borodo MM, Ogun AS, Habib AG. Prevalene and correlated of HIV-associated neurocognitive disorders (HAND) in northwestern Nigeria. Neurol Research Intl 486960.
  1. Nakku J, Kinyanda E, Hoskins S. Prvalence and factors associated with probably hIV dementia in an African population: a corss-sectional study of an HIV/AIDS clinic population. BMC Psychiatry 2013:113;126-133.
  1. Berhe T, Melkamu Y, Amare A. The pattern and predictors of mortality of HIV/AIDS patients with neurlogic manifestation in Ethiopia: a retrospective study. AIDS Research and Therapy 2012:9;1-7.
  1. Velagapudi M, Onaiwu C, Gupta V, Anthone J, Bricker L, Ameri A, Vivekanadan R. Cytomegalovirus (CMV) encephalitis in HIV patients. J Neurologic Disorders 2016:4;8- 9.
  2. Muller M, Wandel S, Colebunders R, Attia S, Furrer H, Egger M. Immune resonstitution inflammatory syndrome in patients starting antiretroviral therapy for hIV infection: a systematic review and meta-analysis. Lancet Infect Dis 2010:10;251-261.
  1. Post MJD, Thurnher MM, Clifford DB, Nath A, Gonzalez RG, Gupta RK, Post KK. NS-immune reconstitution inflammatory syndrome in the setting HIV infection. Part 2: discussion of neuro-immune-reconstitution inflammatory syndrome with and without other pathogens. AJNR 2013:34;1308-1318.



Latest revision: 5-14-2021